Laurus Labs Shares Decline After Promoters Sell Stake Worth Rs 500 Crore
Shares of pharmaceutical firm Laurus Labs fell between 3.5% and nearly 9% following promoters' sale of over 20 lakh shares worth around Rs 500 crore. Founder and CEO Satyanarayana Chava sold the majority stake, alongside other promoters. The stock had recently surged over 120% in one year, reaching a 52-week high. Laurus Labs reported a consolidated net profit of Rs 441 crore for Q2, driven by growth in CDMO and affordable medicine segments, and announced acquisitions to expand its market presence.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (54/100). Lens Score 41/100.
Outlets measured: economictimes, moneycontrol. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (52–55/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
moneycontrol broke this story on 16 Nov, 06:48 am. Other outlets followed.
